Skip to main content
. 2020 Aug 10;31(6):e83. doi: 10.3802/jgo.2020.31.e83

Table 3. Percentage of reclassified patients in each subset.

Reclassification Patients with BRCA1 VUS (n=82) Patients with BRCA2 VUS (n=90) Patients with BRCA1 VUS+BRCA2 VUS (n=23) Total (n=195)
Benign 26 (31.7) 20 (22.2) 3 (13.0) 49 (25.1)
Likely benign 3 (3.7) 24 (26.7) 5 (21.7) 32 (16.4)
VUS 39 (47.6) 42 (46.6) 13 (56.5) 94 (48.2)
Likely pathogenic 5 (6.1) 4 (4.4) 1 (4.3) 10 (5.1)
Pathogenic 9 (11.0) 0 (0.0) 1 (4.3) 10 (5.1)

VUS, variants of unknown.